1. Home
  2. ADN vs HUGE Comparison

ADN vs HUGE Comparison

Compare ADN & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADN
  • HUGE
  • Stock Information
  • Founded
  • ADN 2006
  • HUGE 1998
  • Country
  • ADN United States
  • HUGE Canada
  • Employees
  • ADN N/A
  • HUGE N/A
  • Industry
  • ADN Power Generation
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADN Utilities
  • HUGE Health Care
  • Exchange
  • ADN Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • ADN 8.6M
  • HUGE 7.8M
  • IPO Year
  • ADN N/A
  • HUGE N/A
  • Fundamental
  • Price
  • ADN $3.77
  • HUGE $0.15
  • Analyst Decision
  • ADN Hold
  • HUGE
  • Analyst Count
  • ADN 1
  • HUGE 0
  • Target Price
  • ADN $18.00
  • HUGE N/A
  • AVG Volume (30 Days)
  • ADN 21.1K
  • HUGE 2.4M
  • Earning Date
  • ADN 07-30-2024
  • HUGE 07-22-2024
  • Dividend Yield
  • ADN N/A
  • HUGE N/A
  • EPS Growth
  • ADN N/A
  • HUGE N/A
  • EPS
  • ADN N/A
  • HUGE N/A
  • Revenue
  • ADN $5,310,000.00
  • HUGE N/A
  • Revenue This Year
  • ADN N/A
  • HUGE N/A
  • Revenue Next Year
  • ADN $2,705.94
  • HUGE N/A
  • P/E Ratio
  • ADN N/A
  • HUGE N/A
  • Revenue Growth
  • ADN N/A
  • HUGE N/A
  • 52 Week Low
  • ADN $2.70
  • HUGE $0.13
  • 52 Week High
  • ADN $30.00
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • ADN 58.96
  • HUGE 31.94
  • Support Level
  • ADN $3.63
  • HUGE $0.14
  • Resistance Level
  • ADN $3.95
  • HUGE $0.15
  • Average True Range (ATR)
  • ADN 0.27
  • HUGE 0.02
  • MACD
  • ADN 0.09
  • HUGE 0.01
  • Stochastic Oscillator
  • ADN 83.70
  • HUGE 35.19

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: